HK1201299A1 - Methods of diagnosing and treating idiopathic pulmonary fibrosis - Google Patents

Methods of diagnosing and treating idiopathic pulmonary fibrosis

Info

Publication number
HK1201299A1
HK1201299A1 HK15101658.4A HK15101658A HK1201299A1 HK 1201299 A1 HK1201299 A1 HK 1201299A1 HK 15101658 A HK15101658 A HK 15101658A HK 1201299 A1 HK1201299 A1 HK 1201299A1
Authority
HK
Hong Kong
Prior art keywords
diagnosing
methods
pulmonary fibrosis
idiopathic pulmonary
treating idiopathic
Prior art date
Application number
HK15101658.4A
Other languages
English (en)
Chinese (zh)
Inventor
Karl Kossen
Sharlene Lim
Xiaoli Qin
Williamson Ziegler Bradford
Scott D Seiwert
Original Assignee
Intermune Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Intermune Inc filed Critical Intermune Inc
Publication of HK1201299A1 publication Critical patent/HK1201299A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/178—Oligonucleotides characterized by their use miRNA, siRNA or ncRNA

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Pulmonology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Nuclear Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Apparatus For Radiation Diagnosis (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
HK15101658.4A 2011-11-22 2015-02-13 Methods of diagnosing and treating idiopathic pulmonary fibrosis HK1201299A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161562770P 2011-11-22 2011-11-22
US201261648548P 2012-05-17 2012-05-17
PCT/US2012/066221 WO2013078283A1 (fr) 2011-11-22 2012-11-21 Procédés de diagnostic et de traitement de la fibrose pulmonaire idiopathique

Publications (1)

Publication Number Publication Date
HK1201299A1 true HK1201299A1 (en) 2015-08-28

Family

ID=47258131

Family Applications (2)

Application Number Title Priority Date Filing Date
HK15101658.4A HK1201299A1 (en) 2011-11-22 2015-02-13 Methods of diagnosing and treating idiopathic pulmonary fibrosis
HK15101592.3A HK1201298A1 (en) 2011-11-22 2015-02-13 Methods of diagnosing and treating idiopathic pulmonary fibrosis

Family Applications After (1)

Application Number Title Priority Date Filing Date
HK15101592.3A HK1201298A1 (en) 2011-11-22 2015-02-13 Methods of diagnosing and treating idiopathic pulmonary fibrosis

Country Status (11)

Country Link
US (1) US20130150426A1 (fr)
EP (1) EP2783016A1 (fr)
JP (1) JP2015504307A (fr)
CN (1) CN103987858A (fr)
AU (1) AU2012340698A1 (fr)
BR (1) BR112014012288A2 (fr)
CA (1) CA2853136A1 (fr)
EA (1) EA201491019A1 (fr)
HK (2) HK1201299A1 (fr)
MX (1) MX2014006130A (fr)
WO (1) WO2013078283A1 (fr)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2986538B1 (fr) * 2012-02-06 2016-03-11 Centre Nat Rech Scient Utilisation du mir-199a-5p de ses cibles et/ou inhibiteurs pour le diagnostic, le pronostic et le traitement des pathologies fibroproliferatives
EP2852669B1 (fr) 2012-05-22 2018-07-18 Ruprecht-Karls-Universität Heidelberg Cibles thérapeutiques micro arn dans des maladies pulmonaires chroniques
CN104560991B (zh) * 2013-10-10 2021-02-26 复旦大学附属妇产科医院 用于防治人乳头瘤病毒感染和宫颈癌的微小rna
GB201403489D0 (en) * 2014-02-27 2014-04-16 Univ London Queen Mary Biomarkers for endometriosis
US20170226507A1 (en) * 2014-05-05 2017-08-10 The Brigham And Women's Hospital, Inc. Coordinate control of pathogenic signaling by the mir-130/301 family in pulmonary hypertension and fibroproliferative diseases
CN105132525B (zh) * 2014-05-29 2018-11-09 中国医学科学院基础医学研究所 miRNA分子在精神分裂症的诊断和预后中的用途
EP2957634A1 (fr) * 2014-06-20 2015-12-23 Consejo Superior De Investigaciones Científicas Composés pour la prévention et/ou le traitement de maladies fibrotiques
CA2960387A1 (fr) 2014-09-08 2016-03-17 MiRagen Therapeutics, Inc. Mimetiques de mir-29 et leurs utilisations
WO2016054094A1 (fr) 2014-09-30 2016-04-07 Research Institute At Nationwide Children's Hospital Compositions et procédés destinés au traitement de la fibrose hépatique
CN112063714A (zh) * 2014-10-28 2020-12-11 广州复能基因有限公司 一种与结直肠癌相关的miRNA及其应用
CN104450707B (zh) * 2014-12-25 2017-08-29 厦门大学 一种血清miRNA生物标志物的应用
CN104694542A (zh) * 2015-03-19 2015-06-10 中国人民解放军第四军医大学 一种促进组织工程骨血管化的 microRNA 及其应用
CN105079808B (zh) * 2015-05-22 2018-04-03 重庆医科大学 miR590的用途及其相关药物
JP2018517418A (ja) * 2015-06-15 2018-07-05 ザ ボード オブ トラスティーズ オブ ザ レランド スタンフォード ジュニア ユニバーシティー 情動障害の診断および治療の方法
GB201513128D0 (en) * 2015-07-24 2015-09-09 Sense Biodetection Ltd Nucleic acid detection method
CN105106972A (zh) * 2015-08-13 2015-12-02 常州市第一人民医院 miR-338-5p及靶向作用于miR-338-5p核酸制剂的新用途
CN105169393B (zh) * 2015-08-31 2018-07-03 北京泱深生物信息技术有限公司 miRNA-548a-3p抗急性髓系白血病中的应用
CN109477144B (zh) 2015-09-29 2022-12-09 国家儿童医院研究所 用于检测肝脏纤维化和对疗法的响应性的方法
JP2017143810A (ja) * 2016-02-19 2017-08-24 学校法人慶應義塾 抗酸菌症又は抗酸菌感染のバイオマーカー
CN106011303B (zh) * 2016-08-08 2019-05-24 南京市妇幼保健院 一种与儿童肥胖相关的血清或血浆miRNA标志物及其应用
WO2018170622A1 (fr) * 2017-03-18 2018-09-27 深圳市博奥康生物科技有限公司 Procédé de régulation négative synchrone des expressions de miarn-152 et de miarn-185
WO2018170652A1 (fr) * 2017-03-19 2018-09-27 深圳市博奥康生物科技有限公司 Arn tud pour le knockdown multiple de trois miarn et application associée
CN107236799B (zh) * 2017-06-15 2020-06-09 昆明医科大学第六附属医院 一种肾纤维化miRNA标记物
CN108186564B (zh) * 2018-01-03 2020-06-02 上海市肿瘤研究所 一种肿瘤微环境响应型基因纳米胶束及其制备方法和应用
CN108611414A (zh) * 2018-04-26 2018-10-02 北京工业大学 新的靶向肿瘤微环境与肺癌干细胞相互作用的miRNA的检测及应用
CN109486911A (zh) * 2018-11-28 2019-03-19 上海纳米技术及应用国家工程研究中心有限公司 基于滚环扩增和DNA折纸术检测microRNAs的方法
CN109825575A (zh) * 2019-04-08 2019-05-31 首都医科大学附属北京胸科医院 辅助诊断结核病的miRNA标志物及其应用
CN110055322A (zh) * 2019-05-12 2019-07-26 青岛大学 用于急性心肌梗死诊断的循环miRNA标志物及其应用
AU2020291792A1 (en) * 2019-06-14 2022-01-27 Cardior Pharmaceuticals Gmbh Treatment of heart failure in human subjects
CA3146436A1 (fr) 2019-07-16 2021-01-21 Universite De Liege Vesicules extracellulaires contenant mir-142-3p pour traiter des maladies fibrosantes
JP7392224B2 (ja) * 2020-02-19 2023-12-06 国立医薬品食品衛生研究所長 びまん性肺胞傷害型薬剤性間質性肺炎のｍｉＲＮＡ診断バイオマーカー

Family Cites Families (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5430136A (en) 1984-10-16 1995-07-04 Chiron Corporation Oligonucleotides having selectably cleavable and/or abasic sites
US5359100A (en) 1987-10-15 1994-10-25 Chiron Corporation Bifunctional blocked phosphoramidites useful in making nucleic acid mutimers
US5124246A (en) 1987-10-15 1992-06-23 Chiron Corporation Nucleic acid multimers and amplified nucleic acid hybridization assays using same
US5310562A (en) 1989-11-22 1994-05-10 Margolin Solomon B Composition and method for reparation and prevention of fibrotic lesions
US5681697A (en) 1993-12-08 1997-10-28 Chiron Corporation Solution phase nucleic acid sandwich assays having reduced background noise and kits therefor
US5580731A (en) 1994-08-25 1996-12-03 Chiron Corporation N-4 modified pyrimidine deoxynucleotides and oligonucleotide probes synthesized therewith
US5597909A (en) 1994-08-25 1997-01-28 Chiron Corporation Polynucleotide reagents containing modified deoxyribose moieties, and associated methods of synthesis and use
US5681702A (en) 1994-08-30 1997-10-28 Chiron Corporation Reduction of nonspecific hybridization by using novel base-pairing schemes
US6090822A (en) 1995-03-03 2000-07-18 Margolin; Solomon B. Treatment of cytokine growth factor caused disorders
US6114353A (en) 1995-03-03 2000-09-05 Margolin; Solomon B. Compositions and method for treatment of lymphomas, leukemias, and leiomyomas
US5962478A (en) 1995-09-19 1999-10-05 Margolin; Solomon B. Inhibition of tumor necrosis factor α
US7785842B2 (en) 1996-03-26 2010-08-31 Oncomedx, Inc. Comparative analysis of extracellular RNA species
WO2001060819A1 (fr) 2000-02-18 2001-08-23 Kirin Beer Kabushiki Kaisha Nouveaux composes d'isoxazole et de thiazole et leur utilisation en tant que medicaments
US6956044B1 (en) 2000-02-21 2005-10-18 Margolin Solomon B Compositions and methods for treatment of epilepsy
EP1364659B1 (fr) 2001-02-08 2009-11-11 Ono Pharmaceutical Co., Ltd. Remedes pour des maladies urinaires contenant des agents de regulation du recepteur de lpa
CA2476012C (fr) 2002-02-14 2011-04-19 Pharmacia Corporation Pyridinones substituees servant de modulateurs de la map kinase p38
JP2005027804A (ja) 2003-07-10 2005-02-03 Konica Minolta Medical & Graphic Inc 診察支援システム、データ処理端末及びデータ処理プログラム
WO2005012269A1 (fr) 2003-08-05 2005-02-10 Ajinomoto Co., Inc. Nouveau compose azole
WO2005047256A1 (fr) 2003-11-14 2005-05-26 Shanghai Genomics, Inc. Derives de pyridone, et utilisation correspondante
WO2005111211A2 (fr) 2004-05-14 2005-11-24 Rosetta Genomics Ltd. Micro-arn et utilisations de ceux-ci
US20060292616A1 (en) 2005-06-23 2006-12-28 U.S. Genomics, Inc. Single molecule miRNA-based disease diagnostic methods
US20110159111A1 (en) * 2006-06-29 2011-06-30 Astex Therapeutics Limited Pharmaceutical combinations
DK2799427T3 (en) 2006-07-05 2018-10-22 Fibrotech Therapeutics Pty Ltd Therapeutic compounds
US8383823B2 (en) 2007-06-20 2013-02-26 Auspex Pharmaceuticals Substituted N-aryl pyridinones
US20090131485A1 (en) 2007-09-10 2009-05-21 Concert Pharmaceuticals, Inc. Deuterated pirfenidone
JP2011505143A (ja) * 2007-11-30 2011-02-24 ジ・オハイオ・ステイト・ユニバーシティ・リサーチ・ファウンデイション マイクロｒｎａ発現プロファイリング及び肺癌における末梢血ターゲティング
WO2009099901A1 (fr) 2008-02-01 2009-08-13 Amira Pharmaceuticals, Inc. Antagonistes aminoalkylbiphényle n, n' disubstitués des récepteurs d2 de la prostaglandine
JP2011512359A (ja) 2008-02-14 2011-04-21 アミラ ファーマシューティカルズ，インク． プロスタグランジンｄ２受容体のアンタゴニストとしての環式ジアリールエーテル化合物
EP2096171A1 (fr) * 2008-02-27 2009-09-02 Julius-Maximilians-Universität Würzburg Cibles microARN (miARN) et en aval à des fins de diagnostic et thérapeutiques
WO2010039502A2 (fr) * 2008-09-23 2010-04-08 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Microarn afférents à la fibrose pulmonaire idiopathique
EP4219760A3 (fr) * 2008-11-10 2023-09-06 Battelle Memorial Institute Procédés, compositions et dispositifs utilisant un microarn pour déterminer des états physiologiques
WO2010068775A2 (fr) 2008-12-11 2010-06-17 Amira Pharmaceuticals, Inc. Antagonistes d'alcyne de récepteurs d'acide lysophosphatidique
GB2466121B (en) 2008-12-15 2010-12-08 Amira Pharmaceuticals Inc Antagonists of lysophosphatidic acid receptors
US20100190731A1 (en) 2009-01-26 2010-07-29 Jeff Olgin Methods for treating acute myocardial infarctions and associated disorders
EP2436385A4 (fr) * 2009-05-29 2012-10-24 Shizuoka Coffein Co Ltd Agent prophylactique ou thérapeutique pour fibrose pulmonaire
GB2470833B (en) 2009-06-03 2011-06-01 Amira Pharmaceuticals Inc Polycyclic antagonists of lysophosphatidic acid receptors
CN102574822A (zh) 2009-08-04 2012-07-11 阿米拉制药公司 作为溶血磷脂酸受体拮抗剂的化合物
GB2474120B (en) 2009-10-01 2011-12-21 Amira Pharmaceuticals Inc Compounds as Lysophosphatidic acid receptor antagonists
GB2474748B (en) 2009-10-01 2011-10-12 Amira Pharmaceuticals Inc Polycyclic compounds as lysophosphatidic acid receptor antagonists
US7816383B1 (en) * 2009-12-04 2010-10-19 Intermune, Inc. Methods of administering pirfenidone therapy

Also Published As

Publication number Publication date
JP2015504307A (ja) 2015-02-12
WO2013078283A1 (fr) 2013-05-30
US20130150426A1 (en) 2013-06-13
EA201491019A1 (ru) 2014-08-29
CN103987858A (zh) 2014-08-13
CA2853136A1 (fr) 2013-05-30
HK1201298A1 (en) 2015-08-28
BR112014012288A2 (pt) 2017-05-23
EP2783016A1 (fr) 2014-10-01
AU2012340698A1 (en) 2014-04-24
MX2014006130A (es) 2015-04-13

Similar Documents

Publication Publication Date Title
HK1201299A1 (en) Methods of diagnosing and treating idiopathic pulmonary fibrosis
IL256396A (en) Methods of prognosing, diagnosing and treating idiopathic pulmonary fibrosis
HK1193837A1 (zh) 聚脲組合物及其使用方法
IL232977A0 (en) Intra-episode dexmedetomidine preparations and methods of using them
ZA201400141B (en) Keto-isovalerate decarboxylase enzymes and methods of use thereof
EP2670866A4 (fr) Biomarqueurs et leurs procédés d'utilisation
GB201219266D0 (en) Wading appaatus and method
EP2675471A4 (fr) Compositions liées à la sérumalbumine humaine et procédés d'utilisation
EP2710370A4 (fr) Méthodes de diagnostic et de traitement de maladies ou affections pulmonaires
HK1201463A1 (en) Cd40l-specific tn3-derived scaffolds and methods of use thereof cd40l- tn3-
IL260115A (en) Methods for treating fibrosis (Leifat)
EP2790716A4 (fr) Angiotensines pour le traitement d'une fibrose
EP2786788A4 (fr) Volant et son procédé de fabrication
HUE041627T2 (hu) Tisztító készítmények és eljárások
EP2844291A4 (fr) Méthodes de traitement de la fibrose pulmonaire idiopathique
EP2670245A4 (fr) Alpha-cétohétérocycles et leurs procédés de fabrication et d'utilisation
EP2802250A4 (fr) Têtes de nettoyage et procédés d'utilisation
ZA201405829B (en) Cleaning arrangement and method of use
IL233354A0 (en) 2, 6-Dihalo-5-Alkoxy-4-converted-pyrimidines, pyrimidine-carbaldehydes, and methods of production and use
GB201102364D0 (en) Lock means and method of use thereof
PT2811993T (pt) Métodos de tratamento da fibrose
GB201118570D0 (en) Cleaning composition and method
GB201014490D0 (en) Cleaning means and method of use thereof
GB201122402D0 (en) Lock means and method of use thereof
GB201101586D0 (en) Lock means and method of use thereof